LBA11 Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in triple negative breast cancer with high tumor-infiltrating lymphocytes (TILs)
| Autor: | Nederlof, I., Rolfes, A.L., Gielen, R.C.A.M., Awada, G., Dongen, M.V., Horlings, H.M., Van De Vijver, K., Drukker, C.A., van Duijnhoven, F., Lopez-Yurda, M., Mandjes, I., Mann, R.M., Loo, C.E., Blank, C.U., Schumacher, T.N., Salgado, R.F., Kok, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1206-S1206 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|